Early Day Motion·EDM 142

AVAILABILITY OF GLIVEC

23 November 200417 Signatures

Motion Text

That this House supports the guidance issued by the Department of Health ensuring that Glivec, a novel treatment for chronic myeloid leukaemia, is available on the NHS; and calls on NICE to recognise this without restrictions on this drug.